The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Self-administered Parenteral Market Research Report 2025

Global Self-administered Parenteral Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1897821

No of Pages : 97

Ask Your Query
Synopsis
The global Self-administered Parenteral market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Self-administered Parenteral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Self-administered Parenteral is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Self-administered Parenteral include Becton, Dickinson and Company, scPharmaceuticals, Harro Hofliger, Owen Mumford, Haselmeier, Stevanato Group, Ypsomed AG, Solteam Group and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Self-administered Parenteral, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Self-administered Parenteral.
Report Scope
The Self-administered Parenteral market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Self-administered Parenteral market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Self-administered Parenteral manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Becton, Dickinson and Company
scPharmaceuticals
Harro Hofliger
Owen Mumford
Haselmeier
Stevanato Group
Ypsomed AG
Solteam Group
AstraZeneca
Enable lnjections
CCBio
Phillips-Medisize Corporation
Sorrel Medical
Krontec Healthcare
Subcuject Aps
Ascendia Pharmaceuticals
West Pharmaceutical Services, Inc.
Segment by Type
Pre-filled Syringes
Autoinjectors
Pen Injectors
Others
Segment by Application
Pharmacy
Online Sales
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Self-administered Parenteral manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Self-administered Parenteral in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Self-administered Parenteral Market Overview
1.1 Product Overview and Scope of Self-administered Parenteral
1.2 Self-administered Parenteral Segment by Type
1.2.1 Global Self-administered Parenteral Market Value Comparison by Type (2024-2030)
1.2.2 Pre-filled Syringes
1.2.3 Autoinjectors
1.2.4 Pen Injectors
1.2.5 Others
1.3 Self-administered Parenteral Segment by Application
1.3.1 Global Self-administered Parenteral Market Value by Application: (2024-2030)
1.3.2 Pharmacy
1.3.3 Online Sales
1.3.4 Other
1.4 Global Self-administered Parenteral Market Size Estimates and Forecasts
1.4.1 Global Self-administered Parenteral Revenue 2019-2030
1.4.2 Global Self-administered Parenteral Sales 2019-2030
1.4.3 Global Self-administered Parenteral Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Self-administered Parenteral Market Competition by Manufacturers
2.1 Global Self-administered Parenteral Sales Market Share by Manufacturers (2019-2024)
2.2 Global Self-administered Parenteral Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Self-administered Parenteral Average Price by Manufacturers (2019-2024)
2.4 Global Self-administered Parenteral Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Self-administered Parenteral, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Self-administered Parenteral, Product Type & Application
2.7 Self-administered Parenteral Market Competitive Situation and Trends
2.7.1 Self-administered Parenteral Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Self-administered Parenteral Players Market Share by Revenue
2.7.3 Global Self-administered Parenteral Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Self-administered Parenteral Retrospective Market Scenario by Region
3.1 Global Self-administered Parenteral Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Self-administered Parenteral Global Self-administered Parenteral Sales by Region: 2019-2030
3.2.1 Global Self-administered Parenteral Sales by Region: 2019-2024
3.2.2 Global Self-administered Parenteral Sales by Region: 2025-2030
3.3 Global Self-administered Parenteral Global Self-administered Parenteral Revenue by Region: 2019-2030
3.3.1 Global Self-administered Parenteral Revenue by Region: 2019-2024
3.3.2 Global Self-administered Parenteral Revenue by Region: 2025-2030
3.4 North America Self-administered Parenteral Market Facts & Figures by Country
3.4.1 North America Self-administered Parenteral Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Self-administered Parenteral Sales by Country (2019-2030)
3.4.3 North America Self-administered Parenteral Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Self-administered Parenteral Market Facts & Figures by Country
3.5.1 Europe Self-administered Parenteral Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Self-administered Parenteral Sales by Country (2019-2030)
3.5.3 Europe Self-administered Parenteral Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Self-administered Parenteral Market Facts & Figures by Country
3.6.1 Asia Pacific Self-administered Parenteral Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Self-administered Parenteral Sales by Country (2019-2030)
3.6.3 Asia Pacific Self-administered Parenteral Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Self-administered Parenteral Market Facts & Figures by Country
3.7.1 Latin America Self-administered Parenteral Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Self-administered Parenteral Sales by Country (2019-2030)
3.7.3 Latin America Self-administered Parenteral Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Self-administered Parenteral Market Facts & Figures by Country
3.8.1 Middle East and Africa Self-administered Parenteral Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Self-administered Parenteral Sales by Country (2019-2030)
3.8.3 Middle East and Africa Self-administered Parenteral Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Self-administered Parenteral Sales by Type (2019-2030)
4.1.1 Global Self-administered Parenteral Sales by Type (2019-2024)
4.1.2 Global Self-administered Parenteral Sales by Type (2025-2030)
4.1.3 Global Self-administered Parenteral Sales Market Share by Type (2019-2030)
4.2 Global Self-administered Parenteral Revenue by Type (2019-2030)
4.2.1 Global Self-administered Parenteral Revenue by Type (2019-2024)
4.2.2 Global Self-administered Parenteral Revenue by Type (2025-2030)
4.2.3 Global Self-administered Parenteral Revenue Market Share by Type (2019-2030)
4.3 Global Self-administered Parenteral Price by Type (2019-2030)
5 Segment by Application
5.1 Global Self-administered Parenteral Sales by Application (2019-2030)
5.1.1 Global Self-administered Parenteral Sales by Application (2019-2024)
5.1.2 Global Self-administered Parenteral Sales by Application (2025-2030)
5.1.3 Global Self-administered Parenteral Sales Market Share by Application (2019-2030)
5.2 Global Self-administered Parenteral Revenue by Application (2019-2030)
5.2.1 Global Self-administered Parenteral Revenue by Application (2019-2024)
5.2.2 Global Self-administered Parenteral Revenue by Application (2025-2030)
5.2.3 Global Self-administered Parenteral Revenue Market Share by Application (2019-2030)
5.3 Global Self-administered Parenteral Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Becton, Dickinson and Company
6.1.1 Becton, Dickinson and Company Corporation Information
6.1.2 Becton, Dickinson and Company Description and Business Overview
6.1.3 Becton, Dickinson and Company Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Becton, Dickinson and Company Self-administered Parenteral Product Portfolio
6.1.5 Becton, Dickinson and Company Recent Developments/Updates
6.2 scPharmaceuticals
6.2.1 scPharmaceuticals Corporation Information
6.2.2 scPharmaceuticals Description and Business Overview
6.2.3 scPharmaceuticals Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.2.4 scPharmaceuticals Self-administered Parenteral Product Portfolio
6.2.5 scPharmaceuticals Recent Developments/Updates
6.3 Harro Hofliger
6.3.1 Harro Hofliger Corporation Information
6.3.2 Harro Hofliger Description and Business Overview
6.3.3 Harro Hofliger Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Harro Hofliger Self-administered Parenteral Product Portfolio
6.3.5 Harro Hofliger Recent Developments/Updates
6.4 Owen Mumford
6.4.1 Owen Mumford Corporation Information
6.4.2 Owen Mumford Description and Business Overview
6.4.3 Owen Mumford Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Owen Mumford Self-administered Parenteral Product Portfolio
6.4.5 Owen Mumford Recent Developments/Updates
6.5 Haselmeier
6.5.1 Haselmeier Corporation Information
6.5.2 Haselmeier Description and Business Overview
6.5.3 Haselmeier Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Haselmeier Self-administered Parenteral Product Portfolio
6.5.5 Haselmeier Recent Developments/Updates
6.6 Stevanato Group
6.6.1 Stevanato Group Corporation Information
6.6.2 Stevanato Group Description and Business Overview
6.6.3 Stevanato Group Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Stevanato Group Self-administered Parenteral Product Portfolio
6.6.5 Stevanato Group Recent Developments/Updates
6.7 Ypsomed AG
6.6.1 Ypsomed AG Corporation Information
6.6.2 Ypsomed AG Description and Business Overview
6.6.3 Ypsomed AG Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ypsomed AG Self-administered Parenteral Product Portfolio
6.7.5 Ypsomed AG Recent Developments/Updates
6.8 Solteam Group
6.8.1 Solteam Group Corporation Information
6.8.2 Solteam Group Description and Business Overview
6.8.3 Solteam Group Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Solteam Group Self-administered Parenteral Product Portfolio
6.8.5 Solteam Group Recent Developments/Updates
6.9 AstraZeneca
6.9.1 AstraZeneca Corporation Information
6.9.2 AstraZeneca Description and Business Overview
6.9.3 AstraZeneca Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.9.4 AstraZeneca Self-administered Parenteral Product Portfolio
6.9.5 AstraZeneca Recent Developments/Updates
6.10 Enable lnjections
6.10.1 Enable lnjections Corporation Information
6.10.2 Enable lnjections Description and Business Overview
6.10.3 Enable lnjections Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Enable lnjections Self-administered Parenteral Product Portfolio
6.10.5 Enable lnjections Recent Developments/Updates
6.11 CCBio
6.11.1 CCBio Corporation Information
6.11.2 CCBio Self-administered Parenteral Description and Business Overview
6.11.3 CCBio Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.11.4 CCBio Self-administered Parenteral Product Portfolio
6.11.5 CCBio Recent Developments/Updates
6.12 Phillips-Medisize Corporation
6.12.1 Phillips-Medisize Corporation Corporation Information
6.12.2 Phillips-Medisize Corporation Self-administered Parenteral Description and Business Overview
6.12.3 Phillips-Medisize Corporation Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Phillips-Medisize Corporation Self-administered Parenteral Product Portfolio
6.12.5 Phillips-Medisize Corporation Recent Developments/Updates
6.13 Sorrel Medical
6.13.1 Sorrel Medical Corporation Information
6.13.2 Sorrel Medical Self-administered Parenteral Description and Business Overview
6.13.3 Sorrel Medical Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Sorrel Medical Self-administered Parenteral Product Portfolio
6.13.5 Sorrel Medical Recent Developments/Updates
6.14 Krontec Healthcare
6.14.1 Krontec Healthcare Corporation Information
6.14.2 Krontec Healthcare Self-administered Parenteral Description and Business Overview
6.14.3 Krontec Healthcare Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Krontec Healthcare Self-administered Parenteral Product Portfolio
6.14.5 Krontec Healthcare Recent Developments/Updates
6.15 Subcuject Aps
6.15.1 Subcuject Aps Corporation Information
6.15.2 Subcuject Aps Self-administered Parenteral Description and Business Overview
6.15.3 Subcuject Aps Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Subcuject Aps Self-administered Parenteral Product Portfolio
6.15.5 Subcuject Aps Recent Developments/Updates
6.16 Ascendia Pharmaceuticals
6.16.1 Ascendia Pharmaceuticals Corporation Information
6.16.2 Ascendia Pharmaceuticals Self-administered Parenteral Description and Business Overview
6.16.3 Ascendia Pharmaceuticals Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Ascendia Pharmaceuticals Self-administered Parenteral Product Portfolio
6.16.5 Ascendia Pharmaceuticals Recent Developments/Updates
6.17 West Pharmaceutical Services, Inc.
6.17.1 West Pharmaceutical Services, Inc. Corporation Information
6.17.2 West Pharmaceutical Services, Inc. Self-administered Parenteral Description and Business Overview
6.17.3 West Pharmaceutical Services, Inc. Self-administered Parenteral Sales, Revenue and Gross Margin (2019-2024)
6.17.4 West Pharmaceutical Services, Inc. Self-administered Parenteral Product Portfolio
6.17.5 West Pharmaceutical Services, Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Self-administered Parenteral Industry Chain Analysis
7.2 Self-administered Parenteral Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Self-administered Parenteral Production Mode & Process
7.4 Self-administered Parenteral Sales and Marketing
7.4.1 Self-administered Parenteral Sales Channels
7.4.2 Self-administered Parenteral Distributors
7.5 Self-administered Parenteral Customers
8 Self-administered Parenteral Market Dynamics
8.1 Self-administered Parenteral Industry Trends
8.2 Self-administered Parenteral Market Drivers
8.3 Self-administered Parenteral Market Challenges
8.4 Self-administered Parenteral Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock